Publications by authors named "D Lazzarotto"

Claim this Profile
P
Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group.
Davide Lazzarotto, Anna Maria Testi, Matteo Fanin, Federico Mosna, Sabina Chiaretti

Ann Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Adult Lymphoblastic Lymphoma Patients Treated in the Real Life According to the Gimema LAL1913 Protocol: A Campus ALL Multicenter Study.
M Delia, D Lazzarotto, S Imbergamo, F Mosna, C Papayannidis

Hematol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stenotrophomonas maltophilia infections: Could eravacycline be a new weapon for clinicians?
Simone Giuliano, Luca Martini, Francesca Prataviera, Chiara Moreal, Sarah Flammini, Davide Lazzarotto

New Microbiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Incidence and Etiology of Infectious Complications in Adults With Ph-Negative Acute Lymphoblastic Leukemia Treated With the Pediatric-Inspired GIMEMA LAL1913 Program. A Campus All Study.
Patrizia Zappasodi, Ludovica Calabretta, Virginia Valeria Ferretti, Davide Lazzarotto, Nicola Fracchiolla

Hematol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eravacycline: Data Based on Real Evidence.
Simone Giuliano, Luca Martini, Francesca Prataviera, Chiara Moreal, Sarah Flammini, Davide Lazzarotto

New Microbiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis